Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) EBT Margin (2016 - 2025)

Historic EBT Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 14.32%.

  • Veracyte's EBT Margin fell 2200.0% to 14.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.26%, marking a year-over-year increase of 81800.0%. This contributed to the annual value of 5.78% for FY2024, which is 269900.0% up from last year.
  • Latest data reveals that Veracyte reported EBT Margin of 14.32% as of Q3 2025, which was down 2200.0% from 0.96% recorded in Q2 2025.
  • In the past 5 years, Veracyte's EBT Margin registered a high of 14.54% during Q3 2024, and its lowest value of 124.41% during Q1 2021.
  • Moreover, its 5-year median value for EBT Margin was 9.82% (2023), whereas its average is 14.4%.
  • As far as peak fluctuations go, Veracyte's EBT Margin crashed by -867700bps in 2021, and later soared by 1030700bps in 2022.
  • Over the past 5 years, Veracyte's EBT Margin (Quarter) stood at 16.81% in 2021, then surged by 75bps to 4.29% in 2022, then tumbled by -624bps to 31.03% in 2023, then skyrocketed by 109bps to 2.9% in 2024, then soared by 394bps to 14.32% in 2025.
  • Its last three reported values are 14.32% in Q3 2025, 0.96% for Q2 2025, and 6.49% during Q1 2025.